Myelin oligodendrocyte glycoprotein (MOG) antibodies in a patient with glioblastoma: Red flags for false positivity

Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing

(2021) Elia Sechi et al.   JAMA Neurology

Myelin-oligodendrocyte glycoprotein antibody-associated disease

(2021) Romain Marignier et al.   LANCET NEUROLOGY

Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder

(2020) John J. Chen et al.   NEUROLOGY

Long-term Outcomes in Patients With Myelin Oligodendrocyte Glycoprotein Immunoglobulin G–Associated Disorder

(2020) Sebastian Lopez-Chiriboga et al.   JAMA Neurology

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing

(2018) S. Jarius et al.   Journal of Neuroinflammation

Myelin oligodendrocyte glycoprotein antibodies in neurological disease

(2018) Markus Reindl et al.   Nature Reviews Neurology

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination

(2017) Sudarshini Ramanathan et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY